We have not found any cost information for this lawyer
Tedd W. Van Buskirk
About Tedd
Biography
Over the past 25 years, I have dedicated my practice to intellectual property law. I litigate and prosecute patents and trademarks and counsel clients on a variety of intellectual property issues, both domestic and international. As a trial attorney, my emphasis is on Hatch-Waxman ANDA litigation arising between brand and generic drug manufacturers. My peers have awarded me an AV Preeminent rating through Martindale Hubbell.
Specialties:
Registered Patent Attorney specializing in pharmaceuticals and biotechnology, medical devices, Hatch-Waxman ANDA litigation, counseling and strategy, biosimilars and related FDA issues.
Practice Areas
6
Practice Areas
Intellectual Property
20%
30 years
Life Sciences and Biotechnology
20%
30 years
Patent Application
20%
30 years
Patent Infringement
20%
30 years
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in New York for 29 years
State: New York
Acquired: 1996
No misconduct found
Licensed in New Jersey for 30 years
State: New Jersey
Acquired: 1995
No misconduct found
Location
Lerner, David, Littenberg, Krumholz & Mentlik
20 Commerce Drive, Cranford, NJ, 07016
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Tedd W. Van Buskirk's Reviews
Showing 1 - 1 of 1 client review from Avvo
Posted by Alden | May 25, 2013
Felt Like a Valued Client
Let me preface this review by saying that I am neither wealthy nor a Very Important Person. But Tedd made me feel like one. He responded quickly to my questions and worked efficiently to get the job done. He also took his time to explain everything to me and get to know me as a client. I felt like he...
Tedd W. Van Buskirk's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Honors
2019
AV Preeminent Peer Review Rated, Martindale-Hubbell
2019
Acritas Star, Acritas
2019
LMG Life Sciences Star, LMG
Work Experience
2016 - Present
Partner, Lerner, David, Littenberg, Krumholz & Mentlik
2012 - 2015
Shareholder, Polsinelli PC
2009 - 2012
Partner, K&L Gates
2004 - 2009
Partner, Hogan & Hartson LLP
2001 - 2004
Associate, Frommer, Lawrence & Haug
1998 - 2001
Associate, Milbank, Tweed, Hadley & McCloy LLP
1994 - 1998
Associate, Hopgood, Calimafde, Kalil & Judlowe
Associations
American Intellectual Property Law Association
Member
International Trademark Association
Member
New York Intellectual Property Law Association
Member
Intellectual Property Owners Association
Member
American Chemical Society
Member
Sample of Legal Cases
Amneal Pharmaceuticals LLC v. Alkermes Pharma Ireland Ltd.
pending
Kashiv Pharma LLC v. Purdue Pharma L.P. et al.
pending
Amneal Pharmaceuticals, LLC v. Purdue Pharma L.P. et al.
Final Written Decision of invalidity of all claims
H. Lundbeck A/S et al v. Cipla Limited et al.
pending
Amneal Pharmaceuticals, LLC v. Purdue Pharma L.P. et al.
Final Written Decision of invalidity of all claims
Celgene Corp. v. Lotus Pharm. Co. Ltd. et al.
pending
Mitsubishi Tanabe Pharma Corp., et al. v. Aurobindo, et al.
pending
Takeda Pharmaceutical Co. Ltd et al. v. Torrent Pharmaceuticals Ltd. et al.
pending
Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd.
pending
Accord et al. v. Daiichi Sankyo and Ube
Final Written Decision of invalidity of all claims, affirmed on appeal
Mitsubishi Tanabe Pharma Corporation, et al. v. Sandoz Inc., et al.
pending
Prometheus Laboratories Inc. v. Amneal Pharmaceuticals, LLC et al.
pending
Life Brands v. Monsterops
Favorable settlement
Endo v. Noven
Settled April 2014
Helsinn Healthcare S.A., et al. v. Dr. Reddy's Laboratories, Ltd. et al.
pending
B&E Dimensional Stoneworks v. Wicki et al.
Plaintiff dismissed case in April 2013
Shire v. Taro
Favorable settlement
Medicis v. Taro
Favorable settlement
CIMA Labs Inc. v. Novel Laboratories Inc.
Settled December 2014
Takeda v. Teva
Trial verdict, affirmed on appeal
Akzo Nobel and Organon v. Alphapharm et al.
Favorable settlement following summary judgment
GlaxoSmithKline v. Mutual
Favorable settlement
Collagenex v. URL/Mutual
Medichem v. Rolabo and Stampa v. Jackson
Favorable
Glaxo v. Novopharm et al.
Pfizer v. F&S Alloys & Minerals
Trial verdict
Education
1995
New York Law School
JD - Juris Doctor
1992
The State University of New Jersey, Rutgers College
BA - Bachelor of Arts
Speaking Engagements
2017
Paragraph IV Disputes
The REMS Conundrum: Exploring Challenges for Both Brands and Generics
2016
Paragraph IV Disputes
Parallel Proceedings Moot Court: District Court and PTAB Mock Pharmaceutical Patent Invalidity Hearings
2015
Paragraph IV Disputes
Questions of Specific and General Jurisdiction in a Paragraph IV Case: Exploring Daimler's Applicability to Hatch-Waxman
2013
Paragraph IV Disputes Master Symposium
The Start of the Paragraph IV Litigation Countdown; The Paragraph IV Certication and Notice Letter
2013
Paragraph IV Disputes
Asserting Invalidity or Non-Infringement Under Paragraph IV: Exploring the ANDA Applicant's Pre-Litigation Obligations and Options
2012
Paragraph IV Disputes
The Throwing of the Gauntlet: the Paragraph IV Notice Letter
2010
Paragraph IV Disputes
Litigating with Multiple ANDA Filers: Brand Name and Generic Perspectives
2010
FDA Boot Camp
Patent and IP Overview for Drugs and Biologics: Hatch-Waxman, Trade Dress, and More
2009
10th Anniversary Maximizing Pharmaceutical Patent Life Cycles
Patent and IP Overview for Drugs and Biologics: Hatch-Waxman, Trade Dress, and More
2007
Pharma/Biotech Industry Forum on Patent Portfolio Managment
Controlling Spiraling Costs as Pipelines Get Filled and Portfolios Go Global
2007
Paragraph IV Disputes
Let the Games Begin: The Start of the Paragraph IV Lawsuit - New Considerations, Challenges and Allegations
2006
Maximizing Pharmaceutical Patent Life Cycles
Updated Guidelines for Paragraph IV Certifications and Notice Letters
2005
Maximizing Pharmaceutical Patent Life Cycles
Preparation and Submission of Paragraph IV Certifications and Notice Letters
Publications
2016
New Jersey Law Journal
A Threat to NJ and Del.'s Primacy as Top Venues for Hatch-Waxman Matters?
2015
Law360, Portfolio Media, Inc.
An Update On Hatch-Waxman Personal Jurisdiction Cases
2011
Food and Drug Law Institute (FDLI)
Top 20 Food and Drug Cases, 2010, & Cases to Watch, 2011; Chapter 16 AstraZeneca v. Apotex
Languages
French